2015
DOI: 10.1007/s13410-015-0344-x
|View full text |Cite
|
Sign up to set email alerts
|

Role of prolactin as a cardiovascular risk in type 2 diabetes mellitus patients: a case-control study in Egypt

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…TSH levels have previously been implicated in the development of insulin resistance (IR) and diabetes while TNF-α has been shown to decrease appetite, therefore, lower levels of TNF-α may exasperate obesity related comorbidities by lending to increased positive energy imbalance ( 20 22 ). Amylin is known to be associated with development of type 1 and TIID and increased prolactin levels have been shown to be a cardiovascular risk factor with correlations to diabetes as well ( 23 26 ). However, our previous study was performed with only 58 individuals (29 FA obese, 29 NFA obese).…”
Section: Introductionmentioning
confidence: 99%
“…TSH levels have previously been implicated in the development of insulin resistance (IR) and diabetes while TNF-α has been shown to decrease appetite, therefore, lower levels of TNF-α may exasperate obesity related comorbidities by lending to increased positive energy imbalance ( 20 22 ). Amylin is known to be associated with development of type 1 and TIID and increased prolactin levels have been shown to be a cardiovascular risk factor with correlations to diabetes as well ( 23 26 ). However, our previous study was performed with only 58 individuals (29 FA obese, 29 NFA obese).…”
Section: Introductionmentioning
confidence: 99%